American Journal of Bioethics 20 (9):4-17 (2020)

Authors
Jamie Webb
University of Sussex at Brighton
Abstract
Allocating access to unapproved COVID-19 drugs available via Pre-Approval Access pathways or Emergency Use Authorization raises unique challenges at the intersection of clinical care and research....
Keywords No keywords specified (fix it)
Categories (categorize this paper)
ISBN(s)
DOI 10.1080/15265161.2020.1795529
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 70,214
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Principles of Biomedical Ethics.Tom L. Beauchamp - 1979 - Oxford University Press.
Null. Null - 2016 - Philosophy Study 6 (9).

View all 10 references / Add more references

Citations of this work BETA

Pandemic Ethics and Status Quo Risk.Richard Yetter Chappell - 2022 - Public Health Ethics 15 (1):64-73.

View all 14 citations / Add more citations

Similar books and articles

COVID-19 and Health-Related Authority Allocation Puzzles.Michael da Silva - 2021 - Cambridge Quarterly of Healthcare Ethics 30 (1):25-36.
Medical Research in Clinical Emergency Settings in Europe.S. Lotjonen - 2002 - Journal of Medical Ethics 28 (3):183-187.

Analytics

Added to PP index
2020-08-26

Total views
12 ( #809,638 of 2,507,638 )

Recent downloads (6 months)
1 ( #416,871 of 2,507,638 )

How can I increase my downloads?

Downloads

My notes